Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Alterations in neuronal and glial integrity are considered to be of pathogenic impact on major depressive disorder (MDD). For MDD, data on cerebrospinal fluid (CSF) levels of neuron-specific enolase (NSE) are lacking and scarce for glial protein S100B. METHODS: We measured CSF levels of NSE and S100B in 31 patients with MDD and 32 mentally healthy controls using electrochemiluminescence immunoassays (ECLIA). RESULTS: Adjusted means of NSE were significantly elevated in the MDD patients (11.73 ng/ml (9.95-13.52 95% CI) compared to the controls (6.17 ng/ml (4.55-7.78), F = 9.037, P = 0.004. Effect size for adjusted mean group difference of 5.57 ng/ml was found invariably high (Cohen's d = 1.23). Differentiating MDD from controls, a NSE cut-off of 7.94 ng/ml showed sensitivity of 81% (95% CI 63.7-90.8) and specificity of 75% (95% CI 57.9-86.7). Adjusted levels of S100B did not differ significantly between the two groups (1.12 ng/ml (0.77-1.48) in MDD, 0.97 ng/ml (0.64-1.30) in controls). CONCLUSIONS: Our results of elevated CSF-NSE levels support neuronal pathology in MDD and the potential use of CSF-NSE as marker in clinical diagnostics. Missing group differences in S100B do not promote a specific glial pathology in depressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A systematic review of the mortality of depression
Wulsin, L. R., Vaillant, G. E., & Wells, V. E. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199901000-00003 · Cited by 703 · cited 1×
“Major depressive disorder (MDD) is the leading global cause of years of health lost to disease in both men and women (WHO 2014), belongs to the most common mental disorders with lifetime prevalence of up to 20% ( Kessler et al. 2005 ) and shows high mortality rates of 10% ( Wulsin et al. 1999 ).”
BackgroundAstrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603 · cited 2×
“Both neuronal and glial alterations are regarded to have pathogenic impact on the onset and course of the disorder ( Rajkowska 2000 ; Rajkowska and Stockmeier, 2013 ).”
BackgroundCytokines as biomarkers in depressive disorder: current standing and prospects
Lichtblau, N., Schmidt, F. M., Schumann, R., Kirkby, K. C., & Himmerich, H. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.813442 · Cited by 155
Self-citationSerum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity
Schmidt, F. M., Lichtblau, N., Minkwitz, J., Chittka, T., Thormann, J., Kirkby, K. C., Sander, C., Mergl, R., Faßhauer, M., Stumvoll, M., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.04.021 · Cited by 146 · cited 1×
“…with cytokine release, a consistent fi nding for MDD, as well as S100B itself due to its central and peripheral proinfl ammatory properties, can affect the BBB and should also be considered as a covariate ( Sen et al. 2007 ; Lichtblau et al. 2013 ; Fujiya et al. 2014 ; Schmidt et al. 2014 ).”
BackgroundSelf-citationBanerjee, R., Ghosh, A. K., Ghosh, B., Bhattacharyya, S., & Mondal, A. C. (2013) · Clinical Medicine Insights: Pathology · doi:10.4137/cpath.s12530 · Cited by 135
Neuroimaging genetics: New perspectives in research on major depression?
Frodl, T., Möller, H. ‐., & Meisenzahl, E. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01225.x · Cited by 87
Cited by
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression
Michel, M., Fiebich, B. L., Kuzior, H., Meixensberger, S., Berger, B., Maier, S., Nickel, K., Runge, K., Denzel, D., Pankratz, B., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01423-6 · Cited by 79
Güleş, E., Iosifescu, D. V., & Tural, Ü. (2020) · Neuropsychobiology · doi:10.1159/000505782 · Cited by 42
Zhang, L., Verwer, R. W. H., Zhao, J., Huitinga, I., Lucassen, P. J., & Swaab, D. F. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.098 · Cited by 40
Wang, C.-H., Gu, J.-Y., Zhang, X.-L., Dong, J., Yang, J., Zhang, Y.-L., Ning, Q.-F., Shan, X.-W., & Li, Y. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0116-x · Cited by 33
Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease
Lowes, H., Kurzawa-Akanbi, M., Pyle, A., & Hudson, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-72190-5 · Cited by 21
Metadata
- Authors
- Schmidt, F. M., Mergl, R., Stach, B., Jahn, I., & Schönknecht, P.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2014-09-29
- Volume
- 16
- Issue
- 2
- Pages
- 106-113
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2114142624
- Cited by
- 33
- References
- 7
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.